Home » Topics » BioWorld Science

BioWorld Science
RSS

WDR47, involved in microtubule dynamics and function, is a candidate gene for heterotaxy syndrome

July 4, 2018

CAR-T cell therapy plus allogeneic transplantation in relapsed/refractory B-cell malignancies

July 4, 2018

FDA approves Xeomin for chronic sialorrhea

July 4, 2018

Evotec closes strategic transaction with Sanofi

July 4, 2018

FDA awards orphan drug designation to N-Rephasin for treatment of anthrax

July 4, 2018

Copeptin could be used to diagnose obesity-induced insulin resistance

July 4, 2018

Jiangsu Nhwaluokang Pharmaceutical discovers allopregnanolone prodrugs

July 4, 2018

Titan postpones enrollment in next cohort of phase I/II trial of ropinirole implant

July 4, 2018

Spiramycin approved in Japan for treatment of toxoplasmosis during pregnancy

July 4, 2018

New P2X4 antagonists synthesized by Bayer

July 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Unmasking the X: EPAC2 shifts the fragile X landscape
BioWorld
Researchers at UCLA have shown that divergent neuronal signaling in fragile X mice converges on EPAC2, a druggable target whose inhibition restores circuit...
Recludix presents STAT1/3 inhibitors for dermatological diseases
BioWorld Science
Recludix Pharma Inc. recently presented data on their new STAT1/3 inhibitors REX-6553 and REX-6547 for treating dermatological inflammatory skin diseases.